ACM
NEO icon

Advent Capital Management’s NeoGenomics NEO Stock Holding History

Advent Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,966
Closed -$48K – 195
2023
Q4 		$48K Sell
2,966
-1,534
-34% -$25.1K ﹤0.01% 177
2023
Q3 		$55.4K Buy
+4,500
New +$66.9K ﹤0.01% 198

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Advent Capital Management's NEO Position: Q1 2024 in Review

Advent Capital Management sold out of NeoGenomics (NEO) in Q1 2024, closing a stake of 2,966 shares — an estimated $48K sold.

Advent Capital Management first reported a position in NEO in Q3 2023 and held it in 2 quarters. The position peaked at $55.4K in Q3 2023. 263 funds tracked by Wall St. Rank hold NEO as of Q1 2024.

  • Advent Capital Management reported no remaining NeoGenomics position as of Q1 2024 after selling out during the quarter.
  • Advent Capital Management sold 2,966 NeoGenomics shares in Q1 2024, an estimated $48K.
  • Advent Capital Management first reported a position in NeoGenomics in Q3 2023 and held it in 2 quarters.
  • Advent Capital Management's NeoGenomics position peaked at $55.4K in Q3 2023.
  • 263 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2024.

Based on Advent Capital Management's 13F filing for Q1 2024, filed 14 May 2024.